AZNN
vs
PFE
AZNN
PFE
Over the past 12 months, AZNN has outperformed PFE, delivering a return of +8% compared to the PFE's +4% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
AZNN
PFE
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
AstraZeneca PLC
BMV:AZNN
|
1 628
MXN
|
|||||
|
Pfizer Inc
NYSE:PFE
|
27.12
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
AZNN, PFE
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
AstraZeneca PLC
Revenue
|
|||||||||||
|
Pfizer Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
AZNN, PFE
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
AstraZeneca PLC
BMV:AZNN
|
|||||||||
|
Pfizer Inc
NYSE:PFE
|
|||||||||
Compare company's free cash flow with its competitors.
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
AZNN, PFE
Performance By Year
AZNN, PFE
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|